Letter: propensity score-handle with care. Authors' reply

Aliment Pharmacol Ther. 2021 Jan;53(2):362-363. doi: 10.1111/apt.16211.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Crohn Disease*
  • Humans
  • Propensity Score
  • Tumor Necrosis Factor-alpha
  • Ustekinumab*

Substances

  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • vedolizumab
  • Ustekinumab